Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of TAS-102 and Concurrent Radiation Therapy for Patients With Locally Recurrent, Unresectable or Metastatic, Rectal Cancer

NCT03297710 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03297710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03297710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of TAS-102 and Concurrent Radiation Therapy for Patients With Locally Recurrent, Unresectable or Metastatic, Rectal Cancer
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
December 11, 2017
Completion date
April 30, 2021
Enrollment
7 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rectal adenocarcinoma, recurrent rectal carcinoma, stage iv rectal cancer ajcc v7, stage iva rectal cancer ajcc v7, stage ivb rectal cancer ajcc v7